Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 11, 2015PLoS ONEOpen Access

Examining the Feasibility of Clinical Grade CD271+ Enrichment of Mesenchymal Stromal Cells for Bone Regeneration

View Full Paper
Ask AI
Bookmark
Share

Authors

RCRichard CuthbertLeeds General Infirmary
Peter V. Giannoudis
Peter V. GiannoudisUniversidade Federal de Minas GeraisXWXiao N. WangNewcastle University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cuthbert et al. (2015) studied this question.

synapsesocial.com/papers/6a98dcc152d74751e81ff0d6https://doi.org/10.1371/journal.pone.0117855
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Good Manufacturing Practices Production of Mesenchymal Stem/Stromal Cells2010 · 224 citations
  2. 2Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates2001 · 48 citations
  3. 3Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates2004 · 219 citations
  4. 4CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization2011 · 470 citations
  5. 5High abundance of CD271+ multipotential stromal cells (MSCs) in intramedullary cavities of long bones2011 · 53 citations